News about "Zydus Lifesciences"

Zydus Gets US FDA Approval for Estradiol Patch

Zydus Gets US FDA Approval for Estradiol Patch

Zydus Lifesciences has received the US FDA approval for Estradiol and Levonorgestrel Transdermal System, eligible for 180-day CGT exclusivity.

Zydus Lifesciences | 21/10/2026 | By News Bureau |  120

FYB206 Becomes First Keytruda Biosimilar to Get US FDA Review

FYB206 Becomes First Keytruda Biosimilar to Get US FDA Review

The US FDA has accepted FYB206’s Biologics License Application (BLA) for review, marking the first publicly announced Keytruda biosimilar filing acceptance.

Zydus Lifesciences | 13/10/2026 | By News Bureau |  108

Zydus and MSN Launch First Generic Adempas in US

Zydus and MSN Launch First Generic Adempas in US

Zydus and MSN has launched the first generic Adempas (riociguat) in the US, offering a lower-cost treatment for pulmonary hypertension patients.

Zydus Lifesciences | 06/10/2026 | By News Bureau

Zydus Lifesciences Reports 22 Percent Revenue Growth in Q1 FY27, Advances Innovation Pipeline

Zydus Lifesciences Reports 22 Percent Revenue Growth in Q1 FY27, Advances Innovation Pipeline

Zydus Lifesciences began FY27 with strong double-digit growth, driven by robust performance across India and international formulations, alongside continued progress in manufacturing quality and biosimilar innovation.

Zydus Lifesciences | 12/08/2026 | By News Bureau |  139

Zydus Launches REVAHALE, India's First Once-Daily Nebulised LAMA for COPD

Zydus Launches REVAHALE, India's First Once-Daily Nebulised LAMA for COPD

Zydus launches REVAHALE (revefenacin), India’s first once-daily nebulised LAMA for COPD, offering sustained 24-hour bronchodilation through nebulised delivery.

Zydus Lifesciences | 11/08/2026 | By News Bureau |  102

Zydus Wins US FDA Approval for Generic Indocyanine Green Injection

Zydus Wins US FDA Approval for Generic Indocyanine Green Injection

Zydus has received US Food and Drug Administration (FDA) approval for generic Indocyanine Green Injection, expanding its injectable imaging portfolio and functional dyes business.

Zydus Lifesciences | 06/08/2026 | By News Bureau |  201

Torrent Pharma Recalls Select Semalix Injection Batches Following API-Related Quality Issue

Torrent Pharma Recalls Select Semalix Injection Batches Following API-Related Quality Issue

Torrent Pharmaceuticals has initiated a recall of select batches of Semalix Injection 2 mg and 4 mg after certain semaglutide batches failed quality specifications due to an API-related issue.

Zydus Lifesciences | 10/07/2026 | By News Bureau |  293

Zydus Lifesciences and Sunshine Healthcare Form JV to Boost Pharma Manufacturing in Sri Lanka

Zydus Lifesciences and Sunshine Healthcare Form JV to Boost Pharma Manufacturing in Sri Lanka

Zydus Lifesciences and Sunshine Healthcare launch a Joint Venture (JV) to develop a pharma manufacturing facility at BOI Horana, strengthening Sri Lanka’s supply of quality medicines.

Zydus Lifesciences | 29/06/2026 | By News Bureau |  247

Assertio Announces Completion of Merger with Zydus Lifesciences

Assertio Announces Completion of Merger with Zydus Lifesciences

Assertio has completed its merger with Zydus Lifesciences, becoming a wholly owned subsidiary of the company. Following the acquisition, Assertio shares have been delisted from Nasdaq, with shareholders receiving USD 23.50 per share in cash.

Zydus Lifesciences | 19/06/2026 | By News Bureau |  190

US FDA Grants Priority Review to Zydus Therapeutics' Saroglitazar for Primary Biliary Cholangitis

US FDA Grants Priority Review to Zydus Therapeutics' Saroglitazar for Primary Biliary Cholangitis

Zydus Therapeutics has received US FDA Priority Review (PR) for its New Drug Application (NDA) for saroglitazar in the treatment of Primary Biliary Cholangitis (PBC), supported by phase 3 EPICS-III trial results demonstrating significant biochemical response, with detailed data to be presented at the EASL Congress 2026.

Zydus Lifesciences | 29/05/2026 | By News Bureau |  311


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members